Pacific Trial Durvalumab in Locally Advanced NSCLC Strikingly Positive Data

Corey J. Langer, MD, FACP of the University of Pennsylvania discusses the Pacific Trial overview of Durvalumab in Locally Advanced NSCLC and how it presented strikingly positive data from the 22nd Ann... Author: thoraciconcology Added: 12/27/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts